Basaglar vs Toujeo: Which Basal Insulin Fits Your Patient
Basaglar (glargine U-100) and Toujeo (glargine U-300) differ in concentration, duration, and hypoglycemia risk. Compare profiles to pick the right agent.
4 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 4 of 4 clinical reviews.
Basaglar (glargine U-100) and Toujeo (glargine U-300) differ in concentration, duration, and hypoglycemia risk. Compare profiles to pick the right agent.
A clinical reference for prescribers and pharmacists covering hypoglycemia, weight gain, injection-site reactions, and other adverse events associated with basal insulin analogs, with evidence-based management protocols and dosing guidance.
A 2026 evidence guide to basal insulin selection, switching, monitoring, and safety in older adults, kidney disease, pregnancy, children, and high-dose treatment.
A prescriber-level guide to basal insulin analog titration and tapering algorithms for T1D and T2D, including starting doses, adjustment protocols, and deprescribing strategies backed by clinical trial data.

LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.